(Q34999579)

5 August 2017

1 reference

title

Photodynamic therapy: unapproved uses, dosages, or indications (English)

1 reference

5 August 2017

Katrin A Salva

1

1 reference

5 August 2017

publication date

1 September 2002

1 reference

5 August 2017

published in

Clinics in Dermatology

1 reference

5 August 2017

volume

20

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

571-581

1 reference

A history of photodynamic therapy

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy for cutaneous malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Properties and applications of photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

1 reference

7 January 2021

Photodynamic therapy in dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

1 reference

7 January 2021

The use of porphyrins and non-ionizing radiation for treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy expands its horizons

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Laser and photodynamic therapy in the management of cutaneous malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

The physics of photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

1 reference

7 January 2021

Preclinical examination of first and second generation photosensitizers used in photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Rat reproductive performance following photodynamic therapy with topically administered Photofrin

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Clinical and preclinical photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

How does photodynamic therapy work?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Current status of photodynamic therapy in dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy in oncology: mechanisms and clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Apoptosis is an early event during phthalocyanine photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

1 reference

7 January 2021

Vasoactive amines and eicosanoids interactively regulate both polymorphonuclear leukocyte diapedesis and albumin permeability in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Induction of tumor immunity by photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Vascular effects of photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy in dermatology. Shedding a different light on skin disease

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy for multiple skin cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Indurated telangiectatic plaques. Malignant angioendotheliomatosis (MAE).

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Repeated 5-aminolevulinic acid-based photodynamic therapy following electro-curettage for pigmented basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy using SnET2 for basal cell nevus syndrome: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Treatment of multiple scalp basal cell carcinomas by photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy using topical 5-aminolevulinic acid or methylester aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Treating basal cell carcinoma: has photodynamic therapy come of age?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy in patient with xeroderma pigmentosum

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy in the management of neoplasms of the perianal skin

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Application of photodynamic therapy in plastic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Interstitial photodynamic therapy with rotating and reciprocating optical fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Phototherapy of human tumours using haematoporphyrin derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photoradiation therapy for cutaneous and subcutaneous malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy for treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy: a 5-year study of its effectiveness in the treatment of posterior uveal melanoma, and evaluation of haematoporphyrin uptake and photocytotoxicity of melanoma cells in tissue culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy in dermatology: recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy for chest wall recurrence in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Interstitial photodynamic therapy. Clinical experience with diffusing fibres in the treatment of cutaneous and subcutaneous tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy for Bowen's disease (squamous cell carcinoma in situ) of the digit

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy: a better treatment for widespread Bowen's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy for treatment of malignant cutaneous lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy and lip vermilion dysplasia: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic cheilitis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Tin-protoporphyrin and long wave length ultraviolet light in treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Systemic photodynamic therapy is a safe and effective treatment for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Treatment of psoriasis by topical photodynamic therapy with polychromatic light

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photochemotherapy of hypervascular dermal lesions: a possible alternative to photothermal therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Clinical Effects of Photodynamic Therapy on Recurrent Laryngeal Papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Treatment of viral infections with 5-aminolevulinic acid and light

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Treatment of recalcitrant verrucae by photodynamic therapy with topical application of delta-aminolaevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Topical photodynamic therapy in verrucae. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Topical ALA-photodynamic therapy for the treatment of acne vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Topical photodynamic therapy for localized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

Killing of cutaneous microbial species by photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2802%2900266-3

7 January 2021

10.1016/S0738-081X(02)00266-3

Identifiers

DOI

1 reference

5 August 2017

1 reference